The term "extrapyramidal effects" describes involuntary movements (movements that you cannot control). These side effects are most common when you first take antipsychotic medications. When you have ...

Entered into an Agreement to be acquired by QOL MedicalNet product sales for the third quarter of 2025 reached $4.3 million; ...

The FDA has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of MDD in adults.

Pre-NDA meeting with FDA to discuss brilaroxazine’s path to approval for schizophrenia planned in Q4 2025 – – Potential NDA ...

The FDA has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults.

The FDA has approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for treating major depressive ...

Titusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CAPLYTA (lumateperone) as an adjunctive therapy with antidepressants for the treatment ...

Pre-NDA meeting with FDA to discuss brilaroxazine's path to approval for schizophrenia planned in Q4 2025 - - Potential NDA submission for schizophrenia indication targeted for Q2 2026 - - European ...

Fortunately, these reactions are rare; among 3775 mental patients treated with potent phenothiazine drugs, Ayd 5 reported 21 per cent with akathisia, 15.4 per cent with pseudoparkinsonism, but only ...

The age of onset of narcolepsy ranges from childhood to the fourth decade of life, with onset after 50s being rare. Onset at an advanced age is one of the factors involved in the delay in diagnosis.

The Department of Neurology, The Royal London Hospital, London E1 1BB, UK Professor Michael Swash, Department of Neurology, The Royal London Hospital, Whitechapel, London E1 1BB, UK. Telephone 0044 ...

Abstract: Parkinson's Disease (PD) is a neurodegenerative disease associated with the extrapyramidal motor system disorder currently being the second most common neurodegenerative disorder. The first ...